| 2022 |
DST–SERB |
Mechanism of GM2-mediated regulation of miR-615-5p in targeting oncogenic ID1 in tumorigenesis |
₹52.72 lakh |
CRG/2021/004623 |
| 2019 |
ICMR |
Understanding the epigenetic regulation of GM2-synthase gene in cancer |
₹45.30 lakh |
2019-0137-CMB/adhoc/BMS |
| 2017 |
DST–SERB |
A novel role of ganglioside GM2 in the regulation of the Hippo Signaling pathway in tumorigenesis |
₹44.16 lakh |
EMR/2016/001983 |
| 2015 |
DBT |
Role of c-Jun N-terminal kinase (JNK) in tumor derived soluble factor mediated T cell apoptosis (Sanctioned July 29, 2015) |
₹24.90 lakh |
6242-P51/RGCB/PMD/DBT/KBWS/2015 |
| 2014 |
DBT |
Studies on the efficacy of flavonoid and non-flavonoid polyphenols against chronic inflammation induced disease pathogenesis |
₹77.41 lakh |
BT/469/NE/TBP/2013 |
| 2014 |
DBT |
Understanding the role of tumor derived glycosphingolipids in carcinogenesis: An in vivo approach |
₹49.00 lakh |
BT/PR5338/MED/30/989/2013 |
| 2011 |
CSIR |
Molecular mechanisms of tumor progression: Role of tumor derived products in mediating tumor cell growth, motility and metastasis |
₹29.00 lakh |
27(0246)/11/EMR-II |
